Clark Wealth Partners’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$639K Sell
7,349
-1,184
-14% -$104K 0.33% 44
2026
Q2
$674K Sell
8,533
-195
-2% -$15.7K 0.38% 41
2026
Q1
$762K Buy
8,728
+291
+3% +$27.9K 0.51% 27
2025
Q4
$810K Hold
8,437
– – 0.49% 28
2025
Q3
$810K Buy
8,437
+1,204
+17% +$111K 0.49% 28
2025
Q2
$631K Sell
7,233
-352
-5% -$29.9K 0.43% 36
2025
Q1
$682K Buy
7,585
+649
+9% +$58.1K 0.51% 30
2024
Q4
$554K Buy
+6,936
New +$600K 0.43% 35

Other funds holding MDT

Clark Wealth Partners's MDT Position: Q3 2026 in Review

Clark Wealth Partners reduced its Medtronic (MDT) stake by 14% in Q3 2026, selling an estimated $104K and leaving 7,349 shares worth $639K. The position accounts for 0.33% of the portfolio, ranked #44.

Clark Wealth Partners first reported a position in MDT in Q4 2024 and has held it in 8 quarters since. The position peaked at $810K in Q4 2025. 1,900 funds tracked by Wall St. Rank hold MDT as of Q3 2026.

  • Clark Wealth Partners held 7,349 shares of Medtronic worth $639K as of Q3 2026.
  • Clark Wealth Partners sold 1,184 Medtronic shares in Q3 2026, an estimated $104K.
  • Medtronic made up 0.33% of Clark Wealth Partners's portfolio in Q3 2026, its #44 holding.
  • Clark Wealth Partners first reported a position in Medtronic in Q4 2024 and has held it in 8 quarters since.
  • Clark Wealth Partners's Medtronic position peaked at $810K in Q4 2025.
  • 1,900 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.

Based on Clark Wealth Partners's 13F filing for Q3 2026, filed 19 Oct 2026.